Dr. Lucas M. Resende Salgado, MD

  • Astoria, NY
  • Radiation oncologist
NPI1306231774PAC ID5092052514
Medicare services, 2024
151
Medicare patients, 2024
40
Part D claims, 2024
137
Publications
10
Hospital affiliations
2
Practice address
23-22 30th Ave, Astoria, NY 11102
Practice phone
Call (212) 241-0025
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Radiation Oncology Department of Mount Sinai

Astoria, New York

See all 5 affiliations

Find Dr. Resende Salgado's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Lucas M. Resende Salgado is a radiation oncologist in Astoria, New York

Dr. Resende Salgado practices at Radiation Oncology Department of Mount Sinai in Astoria, New York.

Dr. Resende Salgado's NPI, 1306231774, was assigned on April 2, 2015. Dr. Resende Salgado graduated from New York University School of Medicine in 2015. Dr. Resende Salgado holds New York license 304213.

NPI and contact details
Medicare PAC ID
5092052514
NPI enumeration date
April 2, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(212) 241-0025
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Lucas M. Resende Salgado practices at Radiation Oncology Department of Mount Sinai in Astoria, New York

Dr. Resende Salgado's primary practice is Radiation Oncology Department of Mount Sinai, at 23-22 30th Ave, Astoria, NY 11102 in Queens County. The practice phone is (212) 241-0025.

  • Radiation Oncology Department of Mount Sinai
    23-22 30th Ave, Astoria, NY 11102 · Queens CountyPhone(212) 241-0025

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Lucas M. Resende Salgado is affiliated with 3 sites of care and 2 medical groups

Dr. Resende Salgado's primary practice is Radiation Oncology Department of Mount Sinai in Astoria, New York. Dr. Resende Salgado is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Resende Salgado to 1 more hospital and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Resende Salgado

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Lucas M. Resende Salgado's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Resende Salgado practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Radiation Oncology Department of Mount SinaiAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Resende Salgado practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Lucas M. Resende Salgado is one of 385 radiation oncologists in New York

Radiation oncology is Dr. Resende Salgado's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Resende Salgado is licensed in New York.

Specialties and state licenses

  • Radiation oncology, New YorkPrimaryLicense 304213 · taxonomy 2085R0001X

Radiation oncologists near Dr. Resende Salgado

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Lucas M. Resende Salgado billed Medicare for 151 services in 2024

CMS data shows 151 Medicare services from Dr. Resende Salgado across 4 procedure codes in 2024, for 40 Medicare patients. Medicare paid $19,196 for them. Every service was in an office.

Medicare services, 2024151
Medicare patients40
Paid by Medicare$19,196
Procedure codes4

Dr. Resende Salgado's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2822024: 9965%
Office and hospital visits
2023: 242024: 52117%
Other services
2023: 4722024: 0100%
Surgery
2023: 152024: 0100%

Dr. Resende Salgado compared with the New York median for radiation oncologists, 2024

  • Dr. Resende Salgado
  • New York median
Medicare services
151vs 1,05486% below
Medicare patients
40vs 16075% below
Part D claims
50vs 3639% above

Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.

Dr. Resende Salgado's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Resende Salgado

Need commercial claims for Dr. Resende Salgado?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Resende Salgado and other radiation oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Lucas M. Resende Salgado treated 40 Medicare patients in 2024, average age 77

CMS counts 40 Medicare patients who saw Dr. Resende Salgado in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Resende Salgado's median patient age at 70, with 42% women.

Medicare patients, 202440
Average age77
Average risk score1.57

Dr. Resende Salgado's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Resende Salgado's Medicare patients by sex, 2024

  • Women1333%
  • Men2768%

Chronic conditions among Dr. Resende Salgado's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes35%
  5. Ischemic heart disease35%

Share of Medicare patients with each condition. A patient can have several.

Dr. Resende Salgado's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women42%
  • Men56%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Lucas M. Resende Salgado wrote 137 Medicare Part D claims in 2024

In 2024, Dr. Resende Salgado wrote 137 Medicare Part D claims for 37 patients. 92% of them were for generic drugs. CMS names the drug for 50 of them, across 1 drug with 11 or more claims each, at $958 in total drug cost. In 2023, CMS named 44 claims across 1 drug.

Part D claims, 2024137
Drugs named by CMS1
Total drug cost$958
Part D patients37

Dr. Resende Salgado's Part D claims by kind of drug, 2024

  • Generic126 claims92%
  • Brand-name11 claims8%

Dr. Resende Salgado's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 442024: 5014%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Resende Salgado

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Lucas M. Resende Salgado offers telehealth to Medicare patients

Dr. Resende Salgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Resende Salgado as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Resende Salgado by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Lucas M. Resende Salgado has 10 publications on record

Dmand AI links 10 papers to Dr. Resende Salgado, published from 2015 to 2024. 2018 was the busiest year, with 2. Dr. Resende Salgado's most frequent co-authors are Kristin T. Hsieh, Kunal K. Sindhu, MD and Richard L. Bakst, MD.

Papers10
Years published2015 to 2024

Dr. Resende Salgado's papers by year, 2015 to 2024

Dr. Resende Salgado's most frequent co-authors

Recent publications by Dr. Resende Salgado

See all 10 publications and co-authors

See who Dr. Resende Salgado researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Resende Salgado works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Lucas M. Resende Salgado received $514 in industry payments from 2020 to 2025

CMS Open Payments shows 8 general payments to Dr. Resende Salgado from 2 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $495.

General payments to Dr. Resende Salgado by program year, 2020 to 2025

Companies that paid Dr. Resende Salgado the most, 2020 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Resende Salgado

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Lucas M. Resende Salgado graduated from New York University School of Medicine

Dr. Resende Salgado graduated from New York University School of Medicine in 2015.

  1. Medical schoolNew York University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Lucas M. Resende Salgado's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Lucas M. Resende Salgado

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Lucas M. Resende Salgado's NPI number?

Dr. Lucas M. Resende Salgado's NPI number is 1306231774. It was assigned on April 2, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Lucas M. Resende Salgado?

Dr. Lucas M. Resende Salgado is a radiation oncologist in Astoria, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Lucas M. Resende Salgado practice?

Dr. Resende Salgado practices at 23-22 30th Ave, Astoria, NY 11102. Dr. Resende Salgado's primary practice is Radiation Oncology Department of Mount Sinai in Astoria, New York. Dmand AI also links Dr. Resende Salgado to 1 hospital and 1 medical group.

What is Dr. Lucas M. Resende Salgado's office phone number?

The practice phone on file for Dr. Resende Salgado is (212) 241-0025.

What is Dr. Lucas M. Resende Salgado's medical license number?

Dr. Resende Salgado holds New York license 304213.

Which hospitals is Dr. Lucas M. Resende Salgado affiliated with?

Dr. Resende Salgado is affiliated with The Mount Sinai Hospital. Dmand AI links Dr. Resende Salgado to 1 more hospital.

What medical group is Dr. Lucas M. Resende Salgado part of?

Dr. Resende Salgado is linked to Mount Sinai Institute for Liver Medicine. Dmand AI links Dr. Resende Salgado to 1 more medical group.

Does Dr. Lucas M. Resende Salgado accept Medicare?

Yes. CMS data shows Dr. Resende Salgado billed Medicare for 151 services in 2024, and Dr. Resende Salgado accepts Medicare assignment.

Does Dr. Lucas M. Resende Salgado offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Resende Salgado as offering telehealth services.

How many Medicare patients does Dr. Lucas M. Resende Salgado see?

CMS counts 40 Medicare patients who saw Dr. Resende Salgado in 2024, with an average age of 77.

Show 7 more questionsShow fewer questions

What services does Dr. Lucas M. Resende Salgado bill to Medicare?

In 2024, Dr. Resende Salgado's most billed Medicare services were radiation oncology (77336), radiation oncology (77427) and office visit, established patient (99214).

Where did Dr. Lucas M. Resende Salgado go to medical school?

Dr. Resende Salgado graduated from New York University School of Medicine in 2015.

What drugs does Dr. Lucas M. Resende Salgado prescribe most?

In 2024 Medicare Part D data, Dr. Resende Salgado's most prescribed drugs by claims were Tamsulosin HCl.

Has Dr. Lucas M. Resende Salgado received payments from drug or device companies?

CMS Open Payments shows $514 in general payments to Dr. Resende Salgado from 2 companies from 2020 to 2025. The largest total came from Novocure Inc.

How long has Dr. Lucas M. Resende Salgado been practicing?

Dr. Resende Salgado graduated from medical school in 2015, 11 years ago.

Does Dr. Lucas M. Resende Salgado do research?

Dmand AI links 10 publications to Dr. Resende Salgado, published from 2015 to 2024.

Who does Dr. Lucas M. Resende Salgado publish with?

Dr. Resende Salgado's most frequent co-authors are Kristin T. Hsieh (3 shared papers), Kunal K. Sindhu, MD (3 shared papers) and Richard L. Bakst, MD (2 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)